Does POLATUZUMAB VEDOTIN Cause Diffuse large b-cell lymphoma recurrent? 177 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 177 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with POLATUZUMAB VEDOTIN (POLIVY). This represents 3.7% of all adverse event reports for POLATUZUMAB VEDOTIN.
177
Reports of Diffuse large b-cell lymphoma recurrent with POLATUZUMAB VEDOTIN
3.7%
of all POLATUZUMAB VEDOTIN reports
32
Deaths
49
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From POLATUZUMAB VEDOTIN?
Of the 177 reports, 32 (18.1%) resulted in death, 49 (27.7%) required hospitalization, and 14 (7.9%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for POLATUZUMAB VEDOTIN. However, 177 reports have been filed with the FAERS database.
What Other Side Effects Does POLATUZUMAB VEDOTIN Cause?
Disease progression (1,131)
Off label use (692)
Anaemia (344)
Blood lactate dehydrogenase increased (307)
Drug ineffective (305)
Neutropenia (303)
Death (295)
Covid-19 (286)
Febrile neutropenia (286)
Pyrexia (285)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which POLATUZUMAB VEDOTIN Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
POLATUZUMAB VEDOTIN vs POLATUZUMAB VEDOTIN-PIIQ
POLATUZUMAB VEDOTIN vs POLIDOCANOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350
POLATUZUMAB VEDOTIN vs POLYETHYLENE GLYCOL 3350\POTASSIUM\SODIUM BICARBONATE\SODIUM